Desmopressin (DDAVP) in the treatment of bleeding disorders: the first 20 years.
Mannucci
P M
PM
Angelo Bianchi Bonomi Hemophilia and Thrombosis Center, IRCSS Maggiore Hospital and University of Milan, Italy.
D000818:Animals; D016063:Blood Loss, Surgical; D003894:Deamino Arginine Vasopressin / Q000266:history / Q000494:pharmacology / Q000627:therapeutic use*; D005169:Factor VIII / Q000096:biosynthesis; D005260:Female; D006467:Hemophilia A / Q000188:drug therapy; D006470:Hemorrhage / Q000517:prevention & control; D006474:Hemorrhagic Disorders / Q000188:drug therapy* / Q000209:etiology / Q000266:history; D049671:History, 18th Century; D049673:History, 20th Century; D006801:Humans; D007558:Italy; D007674:Kidney Diseases / Q000150:complications; D008107:Liver Diseases / Q000150:complications; D008297:Male; D010973:Platelet Adhesiveness / Q000187:drug effects; D011817:Rabbits; D014842:von Willebrand Diseases / Q000188:drug therapy; D014841:von Willebrand Factor / Q000096:biosynthesis
D014841:von Willebrand Factor; D005169:Factor VIII; D003894:Deamino Arginine Vasopressin